FDA Expected To Approve Esketamine Nasal Spray For Depression

NPR | By Jon Hamilton

Published March 4, 2019 at 4:41 PM PST

Facebook
LinkedIn
Email

The Food and Drug Administration is expected to approve a new type of drug for depression. It is esketamine, a chemical cousin of the anesthetic and party drug ketamine.